Hikma to host generics virtual series The Meet the Management virtual event, which is set to highlight the generics business, will be hosted by Hikma’s CEO, Siggi Olafsson, and president of generics, Brian Hoffmann. Surescripts survey: COVID-19 accelerated tech usage, but there is room for growthWhile the majority of pharmacists and prescribers expect the future of health care to be driven by a team-based care model, there is an urgent need to address interoperability needs across the healthcare continuum. Lupin acquires Southern Cross Pharma in Australia With the acquisition, Lupin’s Generic Health subsidiary will gain access to over 60 registered products with sales of approximately $22 million. Amring gets FDA blessing for generic Isuprel Amring’s generic Isuprel is available as 1 ml or 5 ml single-dose vials. Alkem debuts generic Duexis This is the first Food and Drug Administration approval of generic Duexis tablets, the company said. Amneal launches Taytulla generic Taysofy Taytulla and its generic equivalents had a market value of roughly $124.4 million in the 12 months ended June 2021, according to IQVIA. Cardinal Health reports Q4, full-year results for fiscal year 2021 Cardinal Health reported a profit for fourth quarter that dropped from the same period last year. Breckenridge obtains FDA OK for generic Eliquis Eliquis had a market value of $14 billion during the 12 months ended May 2021, according to industry data. Kroger, Lyft partner on discounted rides to COVID-19 vaccine appointments Through the partnership, patients using Kroger’s online COVID-19 vaccine scheduler will receive a Lyft ride code with their appointment confirmation in certain markets. GoodRx partners with Surescripts to provide real-time drug discount pricing Surescripts’ Real-Time Prescription Benefit delivers cost information in the electronic workflow. First Previous 266 267 268 269 270 Next Last